The DSM Annual General Meeting of Shareholders on 11 May 2012 passed a resolution to declare a dividend for 2011 of €1.45 per ordinary share of €1.50 par value. An interim dividend of €0.45 per ordinary share having been paid on 26 August 2011, the final dividend for 2011 will amount to €1.00 per ordinary share. With the passing of the resolution by the AGM, and in line with DSM's policy to provide a stable and preferably rising dividend, 2011 marks the second consecutive year DSM's dividend has been increased.
This final dividend of €1.00 will be paid out in cash or in the form of ordinary shares at the option of the shareholder. Dividend in cash will be paid after deduction of 15% Dutch dividend withholding tax. The ex-dividend date on NYSE Euronext will be 15 May 2012 and the record date will be 17 May 2012.
Shareholders have from 18 May until 1 June 2012 (3.00 pm CET) to indicate their choice. On 4 June 2012 after the close of trading on NYSE Euronext the number of dividend rights of ordinary shares entitling the holder to one ordinary share will be determined.
This exchange ratio will be based on the volume weighted average price of all ordinary shares in DSM traded at NYSE Euronext on 28 May 2012 up to and including 1 June 2012. The value of the stock dividend will be virtually equal to the value of the cash dividend. The ordinary shares that constitute the stock dividend are entitled to any dividend for the financial year 2012 and to the dividends for subsequent financial years. Stock dividend rights will not be traded on NYSE Euronext.
The following timetable applies:
15 May 2012: Ex-dividend quotation
17 May 2012: Record Date
18 May 2012 - 4 June 2012(3.00 pm CET): Period in which shareholders can indicate their choice
04 June 2012 (COB): Announcement of the exchange ratio
06 June 2012: Delivery of shares or cash payment
DSM - Bright Science. Brighter Living.(TM)
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 22,000 employees deliver annual net sales of around €9 billion. The company is listed on NYSE Euronext. More information can be found at www.dsm.com (http://www.dsm.com/).
For more information:
DSM Corporate CommunicationsHerman Bettentel. +31 (0) 45 5782017 e-mail media.relations@dsm.com (mailto:media.relations@dsm.com) | DSM Investor RelationsHans Vossentel. +31 (0) 45 5782864 e-mail investor.relations@dsm.com (mailto:investor.relations@dsm.com) |
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.
Source: DSM N.V. via Thomson Reuters ONE
